What Will AstraZeneca Executive Reshuffle Mean For Asia And Emerging Markets?
This article was originally published in PharmAsia News
Executive Summary
AstraZeneca’s management shakeup will see former China Head Mark Mallon leading the Big Pharma’s International group from Shanghai.